Andrew Hughes
Direktor/Vorstandsmitglied bei CellCentric Ltd.
Aktive Positionen von Andrew Hughes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Manchester Cancer Research Centre | Corporate Officer/Principal | - | - |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 06.04.2022 | - |
Karriereverlauf von Andrew Hughes
Ehemalige bekannte Positionen von Andrew Hughes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PCI BIOTECH HOLDING ASA | Direktor/Vorstandsmitglied | 01.05.2018 | 25.05.2023 |
Independent Dir/Board Member | 01.05.2018 | 25.05.2023 | |
The University of Manchester | Corporate Officer/Principal | 01.01.2006 | - |
AstraZeneca AS | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigtes Königreich | 4 |
Norwegen | 3 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PCI BIOTECH HOLDING ASA | Health Technology |
Private Unternehmen | 3 |
---|---|
AstraZeneca AS | |
Manchester Cancer Research Centre | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Andrew Hughes
- Erfahrung